Cargando…
Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency
OBJECTIVE: CblC deficiency, the most common cobalamin metabolic abnormality, is caused by pathogenic variants in the MMACHC gene. The renal complications of this disease have been described only in a small number of cases. This study aimed to better delineate renal phenotype and genetic characterist...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871484/ https://www.ncbi.nlm.nih.gov/pubmed/36704130 http://dx.doi.org/10.3389/fped.2022.1057594 |
_version_ | 1784877183786811392 |
---|---|
author | Liu, Xiaoyu Xiao, Huijie Yao, Yong Wang, Suxia Zhang, Hongwen Zhong, Xuhui Yang, Yanling Ding, Jie Wang, Fang |
author_facet | Liu, Xiaoyu Xiao, Huijie Yao, Yong Wang, Suxia Zhang, Hongwen Zhong, Xuhui Yang, Yanling Ding, Jie Wang, Fang |
author_sort | Liu, Xiaoyu |
collection | PubMed |
description | OBJECTIVE: CblC deficiency, the most common cobalamin metabolic abnormality, is caused by pathogenic variants in the MMACHC gene. The renal complications of this disease have been described only in a small number of cases. This study aimed to better delineate renal phenotype and genetic characteristics in Chinese children with cblC defect. METHODS: Children with cblC deficiency who manifested as kidney damage were enrolled. Clinical, renal pathological, and genetic data were reviewed in detail. RESULTS: Seven cases were enrolled. Ages at disease onset ranged from 9 months to 5 years. All patients presented with hematuria and proteinuria, and 2/7 cases presented with nephrotic syndrome. Renal dysfunction was observed in 4/7 cases. Renal biopsy was performed in 5/7 cases, and all of them had renal thrombotic microangiopathy. Macrocytic anemia was detected in all seven patients. Six out of seven cases had hypertension, and 2/7 cases presented with pulmonary hypertension. Two of them had a mild intellectual disability, and one suffered from epilepsy. Increased urine methylmalonic acid and plasma homocysteine were detected in seven cases, while two patients had normal levels of urine methylmalonic acid at the initial evaluation. After diagnosis, all seven cases were treated with hydroxocobalamin IM. Six cases were followed-up for 3–8 years. After treatments, anemia was the first to be recovered, followed by proteinuria. Renal function recovered after 1 year in two cases, whereas patient 2 progressed to stage 2 chronic kidney disease 13 years after onset. While a case presented with end-stage kidney disease because of late diagnosis, one case died 3 months after disease onset due to giving up treatment. Three MMACHC pathogenic variants c.80A > G (8/14), c.609G > A (4/14), and c.658_660delAAG (2/14) were detected in all seven children. CONCLUSION: MMACHC variant c.80A > G may be associated with prominent renal complications in Chinese cblC patients. Macrocytic anemia and hyperhomocysteinemia are useful clues for patients with hematuria and proteinuria caused by cblC defect. The most frequent renal pathological manifestation is thrombotic microangiopathy. Early diagnosis and treatment resulted in improving renal and hematological signs. |
format | Online Article Text |
id | pubmed-9871484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98714842023-01-25 Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency Liu, Xiaoyu Xiao, Huijie Yao, Yong Wang, Suxia Zhang, Hongwen Zhong, Xuhui Yang, Yanling Ding, Jie Wang, Fang Front Pediatr Pediatrics OBJECTIVE: CblC deficiency, the most common cobalamin metabolic abnormality, is caused by pathogenic variants in the MMACHC gene. The renal complications of this disease have been described only in a small number of cases. This study aimed to better delineate renal phenotype and genetic characteristics in Chinese children with cblC defect. METHODS: Children with cblC deficiency who manifested as kidney damage were enrolled. Clinical, renal pathological, and genetic data were reviewed in detail. RESULTS: Seven cases were enrolled. Ages at disease onset ranged from 9 months to 5 years. All patients presented with hematuria and proteinuria, and 2/7 cases presented with nephrotic syndrome. Renal dysfunction was observed in 4/7 cases. Renal biopsy was performed in 5/7 cases, and all of them had renal thrombotic microangiopathy. Macrocytic anemia was detected in all seven patients. Six out of seven cases had hypertension, and 2/7 cases presented with pulmonary hypertension. Two of them had a mild intellectual disability, and one suffered from epilepsy. Increased urine methylmalonic acid and plasma homocysteine were detected in seven cases, while two patients had normal levels of urine methylmalonic acid at the initial evaluation. After diagnosis, all seven cases were treated with hydroxocobalamin IM. Six cases were followed-up for 3–8 years. After treatments, anemia was the first to be recovered, followed by proteinuria. Renal function recovered after 1 year in two cases, whereas patient 2 progressed to stage 2 chronic kidney disease 13 years after onset. While a case presented with end-stage kidney disease because of late diagnosis, one case died 3 months after disease onset due to giving up treatment. Three MMACHC pathogenic variants c.80A > G (8/14), c.609G > A (4/14), and c.658_660delAAG (2/14) were detected in all seven children. CONCLUSION: MMACHC variant c.80A > G may be associated with prominent renal complications in Chinese cblC patients. Macrocytic anemia and hyperhomocysteinemia are useful clues for patients with hematuria and proteinuria caused by cblC defect. The most frequent renal pathological manifestation is thrombotic microangiopathy. Early diagnosis and treatment resulted in improving renal and hematological signs. Frontiers Media S.A. 2023-01-10 /pmc/articles/PMC9871484/ /pubmed/36704130 http://dx.doi.org/10.3389/fped.2022.1057594 Text en © 2023 Liu, Xiao, Yao, Wang, Zhang, Zhong, Yang, Ding and Wang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pediatrics Liu, Xiaoyu Xiao, Huijie Yao, Yong Wang, Suxia Zhang, Hongwen Zhong, Xuhui Yang, Yanling Ding, Jie Wang, Fang Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency |
title | Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency |
title_full | Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency |
title_fullStr | Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency |
title_full_unstemmed | Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency |
title_short | Prominent renal complications associated with MMACHC pathogenic variant c.80A > G in Chinese children with cobalamin C deficiency |
title_sort | prominent renal complications associated with mmachc pathogenic variant c.80a > g in chinese children with cobalamin c deficiency |
topic | Pediatrics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871484/ https://www.ncbi.nlm.nih.gov/pubmed/36704130 http://dx.doi.org/10.3389/fped.2022.1057594 |
work_keys_str_mv | AT liuxiaoyu prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency AT xiaohuijie prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency AT yaoyong prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency AT wangsuxia prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency AT zhanghongwen prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency AT zhongxuhui prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency AT yangyanling prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency AT dingjie prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency AT wangfang prominentrenalcomplicationsassociatedwithmmachcpathogenicvariantc80aginchinesechildrenwithcobalamincdeficiency |